Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E59.83 EPS (ttm)1.73 Insider Own0.70% Shs Outstand1.77B Perf Week-3.19%
Market Cap178.68B Forward P/E25.19 EPS next Y4.11 Insider Trans-2.71% Shs Float1.76B Perf Month0.25%
Income3.08B PEG4.01 EPS next Q0.89 Inst Own75.50% Short Float0.49% Perf Quarter16.62%
Sales31.44B P/S5.68 EPS this Y45.20% Inst Trans-0.97% Short Ratio1.65 Perf Half Y38.75%
Book/sh17.25 P/B6.00 EPS next Y24.73% ROA4.60% Target Price115.12 Perf Year25.15%
Cash/sh2.92 P/C35.47 EPS next 5Y14.90% ROE10.10% 52W Range61.61 - 114.19 Perf YTD19.10%
Dividend1.44 P/FCF83.22 EPS past 5Y12.40% ROI8.20% 52W High-8.73% Beta0.93
Dividend %1.39% Quick Ratio1.10 Sales past 5Y9.50% Gross Margin57.70% 52W Low69.17% ATR2.78
Employees107000 Current Ratio1.60 Sales Q/Q-8.20% Oper. Margin12.80% RSI (14)49.48 Volatility2.56% 2.58%
OptionableYes Debt/Eq0.64 EPS Q/Q-46.70% Profit Margin9.90% Rel Volume0.75 Prev Close103.45
ShortableYes LT Debt/Eq0.59 EarningsOct 21 BMO Payout77.40% Avg Volume5.26M Price104.22
Recom1.90 SMA20-1.33% SMA501.29% SMA20014.18% Volume1,341,784 Change0.75%
Sep-11-20Initiated Wolfe Research Outperform $124
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Sep-28-20 11:23AM  
09:01AM  
09:00AM  
Sep-27-20 06:04AM  
Sep-25-20 11:13AM  
10:00AM  
06:03AM  
Sep-24-20 07:01PM  
10:30AM  
07:05AM  
Sep-23-20 05:45PM  
06:12AM  
02:00AM  
Sep-22-20 05:30PM  
04:32PM  
08:51AM  
07:15AM  
Sep-21-20 10:24AM  
09:02AM  
09:00AM  
Sep-18-20 09:26AM  
06:10AM  
05:31AM  
Sep-17-20 09:58PM  
05:45PM  
11:39AM  
09:00AM  
07:00AM  
Sep-15-20 08:00PM  
Sep-14-20 09:41AM  
Sep-13-20 08:00PM  
08:25AM  
06:08AM  
Sep-11-20 08:26PM  
05:45PM  
Sep-10-20 10:58AM  
Sep-09-20 03:21PM  
11:08AM  
10:08AM  
08:08AM  
06:30AM  
Sep-08-20 03:58PM  
Sep-07-20 11:39AM  
08:53AM  
Sep-06-20 08:30AM  
07:10AM  
Sep-05-20 09:34AM  
Sep-04-20 05:45PM  
12:06PM  
09:23AM  
09:15AM  
Sep-03-20 09:27AM  
09:00AM  
Sep-02-20 09:25PM  
07:03PM  
04:13PM  
04:02PM  
09:53AM  
Sep-01-20 09:34PM  
06:43PM  
01:47PM  
12:30PM  
12:29PM  
09:42AM  
09:00AM  
Aug-31-20 01:34PM  
12:33PM  
11:34AM  
11:21AM  
Aug-30-20 09:06AM  
03:24AM  
Aug-28-20 08:32PM  
05:45PM  
05:10PM  
03:29PM  
03:05PM  
03:00PM  
01:51PM  
01:05PM  
11:43AM  
08:26AM  
05:16AM  
01:53AM  
Aug-27-20 11:01PM  
10:56PM  
07:51PM  
07:29PM  
07:22PM  
07:01PM  
06:41PM  
06:26PM  
06:19PM  
05:58PM  
05:25PM  
05:00PM  
04:49PM  
04:39PM  
04:32PM  
04:27PM  
04:25PM  
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wainer Andrea FExecutive Vice PresidentSep 23Sale102.473,650374,03144,080Sep 25 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentSep 11Sale105.282,500263,20046,267Sep 15 06:14 PM
Ginascol John FExecutive Vice PresidentSep 01Option Exercise43.1672,0983,111,584136,775Sep 03 06:33 PM
BIRD ROGERSenior Vice PresidentSep 01Sale108.736,290683,92956,630Sep 03 05:52 PM
CAPEK JOHN MExecutive Vice PresidentAug 27Option Exercise27.0352,3001,413,857369,100Aug 31 06:27 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentAug 27Option Exercise47.0042,4791,996,513144,912Aug 31 06:28 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentAug 27Sale111.8642,4794,751,701102,433Aug 31 06:28 PM
CAPEK JOHN MExecutive Vice PresidentAug 27Sale111.8652,3005,850,278316,800Aug 31 06:27 PM
NOVAKOVIC PHEBE NDirectorJul 23Option Exercise25.053,73993,67732,046Jul 27 05:06 PM
NOVAKOVIC PHEBE NDirectorJul 23Sale100.7893394,02631,113Jul 27 05:06 PM
AUSTIN ROXANNE SDirectorJul 22Sale99.806,844683,03840,043Jul 23 05:07 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 21Option Exercise0.0023,008096,899Jul 23 05:04 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 21Sale98.0023,0082,254,78473,891Jul 23 05:04 PM
Earnhardt Lisa DExecutive Vice PresidentJun 10Sale90.8487279,21672,074Jun 12 05:07 PM
LANE ANDREW HExecutive Vice PresidentMay 05Option Exercise43.8280,0003,505,314145,822May 07 05:02 PM
LANE ANDREW HExecutive Vice PresidentMay 05Sale92.0080,0007,360,10465,822May 07 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentApr 28Sale93.183,724347,01248,767Apr 30 06:34 PM
Funck Robert EExecutive Vice President & CFOApr 21Option Exercise36.4236,7001,336,638206,072Apr 23 09:27 PM
Contreras JaimeSenior Vice PresidentApr 21Option Exercise57.12108,4126,192,995145,431Apr 23 09:26 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Option Exercise22.3950,1001,121,834366,900Apr 23 09:34 PM
Ginascol John FExecutive Vice PresidentApr 21Option Exercise38.4063,2002,426,880129,645Apr 23 09:41 PM
Ginascol John FExecutive Vice PresidentApr 21Sale96.0063,2006,067,05166,445Apr 23 09:41 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Sale95.8750,1004,803,326316,800Apr 23 09:34 PM
Scoggins Christopher JSenior Vice PresidentApr 21Sale96.1041439,78539,706Apr 23 09:28 PM
Boudreau Philip PVice PresidentMar 13Sale82.0010,600869,20022,463Mar 16 06:47 PM
Watkin JaredSenior Vice PresidentMar 06Sale82.008,248676,33668,696Mar 10 05:06 PM
BIRD ROGERSenior Vice PresidentMar 02Sale77.8966651,87562,920Mar 03 05:23 PM
DALE MICHAEL DSenior Vice PresidentMar 02Sale77.8978761,29934,763Mar 03 05:21 PM
Ginascol John FExecutive Vice PresidentMar 02Sale77.636,606512,80566,445Mar 03 05:20 PM
Contreras JaimeSenior Vice PresidentMar 02Sale77.892,001155,85837,019Mar 03 05:19 PM
Watkin JaredSenior Vice PresidentMar 02Sale77.891,761137,16476,944Mar 03 05:19 PM
ALLEN HUBERT LExecutive Vice PresidentMar 02Sale77.891,20894,091151,896Mar 03 05:16 PM
Scoggins Christopher JSenior Vice PresidentMar 02Sale77.891,24096,58441,168Mar 03 05:15 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 02Sale77.8999977,812103,493Mar 03 05:16 PM
BRYNELSEN CHARLESSenior Vice PresidentMar 02Sale77.891,781138,72245,460Mar 03 05:13 PM
Wainer Andrea FExecutive Vice PresidentMar 02Sale77.891,429111,30549,498Mar 03 05:10 PM
Funck Robert EExecutive Vice President & CFOMar 02Sale77.891,356105,619169,372Mar 03 05:28 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentMar 02Sale77.891,420110,60453,859Mar 03 05:27 PM
Moreland Mary KExecutive Vice PresidentFeb 25Sale84.9340033,97266,131Feb 25 05:29 PM
Moreland Mary KExecutive Vice PresidentFeb 19Sale88.971,01990,66052,985Feb 19 05:53 PM
DALE MICHAEL DSenior Vice PresidentFeb 19Sale88.9739635,23223,947Feb 19 05:53 PM
Wainer Andrea FExecutive Vice PresidentFeb 07Sale88.611,12099,24540,140Feb 11 06:10 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Option Exercise45.33509,85023,110,674624,231Jan 30 05:23 PM
YOOR BRIAN BExecutive Vice President & CFOJan 28Sale89.73509,85045,747,209114,381Jan 30 05:23 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Option Exercise38.4037,5001,440,00088,032Jan 29 05:06 PM
MANNING JOSEPH JSenior Vice PresidentJan 27Sale89.5837,5003,359,41150,534Jan 29 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Option Exercise38.4016,000614,40068,562Oct 25 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentOct 23Sale80.5421,0001,691,31547,562Oct 25 05:02 PM